Aspen Pharmacare (South Africa) Today
| APN Stock | 17,130 20.00 0.12% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Aspen Pharmacare is trading at 17130.00 as of the 21st of November 2024, a 0.12 percent decrease since the beginning of the trading day. The stock's lowest day price was 17094.0. Aspen Pharmacare has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Aspen Pharmacare Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of August 2024 and ending today, the 21st of November 2024. Click here to learn more.
Moving against Aspen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aspen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aspen Pharmacare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aspen Pharmacare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Aspen Pharmacare Holdings (APN) is traded on Johannesburg Exchange in South Africa and employs 8,580 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 98.32 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aspen Pharmacare's market, we take the total number of its shares issued and multiply it by Aspen Pharmacare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aspen Pharmacare Holdings operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 444.95 M outstanding shares.
Aspen Pharmacare generates positive cash flow from operations, but has no cash available
Check Aspen Pharmacare Probability Of Bankruptcy
Ownership AllocationAspen Pharmacare holds a total of 444.95 Million outstanding shares. Over half of Aspen Pharmacare's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Aspen Pharmacare. Please watch out for any change in the institutional holdings of Aspen Pharmacare Holdings as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aspen Ownership Details
Aspen Pharmacare Holdings Risk Profiles
Although Aspen Pharmacare's alpha and beta are two of the key measurements used to evaluate Aspen Pharmacare's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.01 | |||
| Standard Deviation | 1.93 | |||
| Variance | 3.73 | |||
| Risk Adjusted Performance | (0.17) |
Aspen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aspen Pharmacare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Aspen Pharmacare Corporate Management
Elected by the shareholders, the Aspen Pharmacare's board of directors comprises two types of representatives: Aspen Pharmacare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aspen. The board's role is to monitor Aspen Pharmacare's management team and ensure that shareholders' interests are well served. Aspen Pharmacare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aspen Pharmacare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lorraine Hill | Group Pharmacist | Profile | |
| Zizipho Mmango | Group Officer | Profile | |
| Carnie Linde | Group Head | Profile | |
| BCom BCom | Group Advisor | Profile | |
| Dip MBA | Group Officer | Profile | |
| ACIS BProc | Group Sec | Profile |
Other Information on Investing in Aspen Stock
Aspen Pharmacare financial ratios help investors to determine whether Aspen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aspen with respect to the benefits of owning Aspen Pharmacare security.